The IMPACT of triple versus dual single-inhaler therapy on exacerbations of COPD

被引：2
|
作者：
Dobler, Claudia C. [1 ]
机构：
[1] Mayo Clin, Evidence Based Practice Ctr, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN 55905 USA
来源：
BREATHE | 2018年 / 14卷 / 04期
基金：
英国医学研究理事会;
关键词：
D O I：
10.1183/20734735.026418
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：333 / 335
页数：3
相关论文
共 50 条
  • [1] Single-Inhaler Triple versus Dual Therapy in Patients with COPD
    Rolla, Giovanni
    Brussino, Luisa
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (06): : 590 - 591
  • [2] Single-Inhaler Triple versus Dual Therapy in Patients with COPD Reply
    Lipson, David A.
    Criner, Gerard J.
    Lomas, David A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (06): : 592 - 593
  • [3] Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
    Lipson, David A.
    Barnhart, Frank
    Brealey, Noushin
    Brooks, Jean
    Criner, Gerard J.
    Day, Nicola C.
    Dransfield, Mark T.
    Halpin, David M. G.
    Han, MeiLan K.
    Jones, C. Elaine
    Kilbride, Sally
    Lange, Peter
    Lomas, David A.
    Martinez, Fernando J.
    Singh, Dave
    Tabberer, Maggie
    Wise, Robert A.
    Pascoe, Steven J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (18): : 1671 - 1680
  • [4] Risk of Exacerbation and Pneumonia with Single-Inhaler Triple versus Dual Therapy in IMPACT
    Dransfield, Mark T.
    Crim, Courtney
    Criner, Gerard J.
    Day, Nicola C.
    Halpin, David M. G.
    Han, MeiLan K.
    Jones, C. Elaine
    Kilbride, Sally
    LaFon, David
    Lipson, David A.
    Lomas, David A.
    Martin, Neil
    Martinez, Fernando J.
    Singh, Dave
    Wise, Robert A.
    Lange, Peter
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (05) : 788 - 798
  • [5] Single-Inhaler Triple versus Dual Bronchodilator Therapy in COPD: Real-World Comparative Effectiveness and Safety
    Suissa, Samy
    Dell'Aniello, Sophie
    Ernst, Pierre
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2022, 17 : 1975 - 1986
  • [6] Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD
    Bourbeau, Jean
    Bafadhel, Mona
    Barnes, Neil C.
    Compton, Chris
    Di Boscio, Valentina
    Lipson, David A.
    Jones, Paul W.
    Martin, Neil
    Weiss, Gudrun
    Halpin, David M. G.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2021, 16 : 499 - 517
  • [7] Is single-inhaler triple therapy for COPD cost-effective in the UK? The IMPACT trial
    Martin, Alan
    Shah, Dhvani
    Ndirangu, Kerigo
    Anley, Glenn A.
    Okorogheye, Gabriel
    Schroeder, Melanie
    Risebrough, Nancy
    Ismaila, Afisi S.
    ERJ OPEN RESEARCH, 2022, 8 (01)
  • [8] Chinese subgroup results from a study comparing single-inhaler triple therapy with dual therapy in COPD
    Liu, Cindy
    Luo, Linda
    Du, Xin
    Xiao, Lochy
    Goh, Aik Han
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [9] Characteristics and treatment pathways of COPD patients initiating single-inhaler dual or triple therapy in England
    Noorduyn, Stephen G.
    Wood, Robert P.
    Rothnie, Kieran J.
    Rai, Kiran K.
    Seif, Monica
    Massey, Lucy
    Compton, Chris
    Ismaila, Afisi S.
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [10] Preventing clinically important deterioration with single-inhaler triple therapy in COPD
    Naya, Ian
    Compton, Chris
    Ismaila, Afisi S.
    Birk, Ruby
    Brealey, Noushin
    Tabberer, Maggie
    Zhu, Chang-Qing
    Lipson, David A.
    Criner, Gerard
    ERJ OPEN RESEARCH, 2018, 4 (04)
12345